VIDEO: Richard Stefanacci, DO, Addresses Cost Concerns of Neurodegenerative Diseases
Richard Stefanacci, DO, Associate Professor, Health Policy & Public Health, University of the Sciences, says there are 2 cost concerns associated with neurodegenerative diseases. One is the actual cost of the disease and the second is the cost of diagnostic testing. Dr Stefanacci also says that treatments are now currently inexpensive, but with new emerging therapiess the costs will rise.
This video was taken on Thursday, November 8 at the NAMCP Fall Forum in Las Vegas, NV.
Leading political outlets report today that shifts in public opinion on the Affordable Care Act (ACA), or at least its components, have led US Senate campaigns to adjust ads accordingly, most notably in Arkansas. However, the changes in tone toward the ACA, often called “Obamacare,” may not change the outcome of the 2014 mid-term elections, according to published reports.
A century ago, employee health and well-being was of such little concern to most US employers that it took the passage of workers’ compensation laws for most to care, because suddenly it affected the bottom line.
Insurers are trapped between pharmaceutical companies developing increasingly expensive drug treatments, and states that want to reduce the patient-burden of co-pays. Additionally, states like New York and Alaska have banned payers from using specialty formularies.
Reports that information on 4.5 million patients from 26 states had been hacked from more than 200 hospitals stunned consumers and the health care community yesterday, even though experts in health information technology have warned of this possibility for some time. News of the hacking incident within Community Health Systems comes as the top US official charged with overseeing the nation’s health information technology (HIT) is trying to educate patients about what to expect about the use of their healthcare information.